Trade Tracker: Jim Lebenthal buys more Abbvie

Jim Lebenthal, Chief Equity Strategist at Cerity Partners, joins CNBC's "Halftime Report" to explain why he's buying more. The Investment committee discuss the health care sector.

[davidwysocki]

Jim Lebenthal is spot-on about ABBV. I have owned ABBV for a long time at a cost basis of $78.29.

[StarAlice-fi]

Better talk about the main trend of this year—providing liquidity. Dont forget to mention Cryptonica; their impact on the market is huge.

[DanaLynch-ht]

You're doing a fantastic job! I need some advice: I have a SafePal wallet with USDT, and I have the seed phrase. (alarm fetch churn bridge exercise tape speak race clerk couch crater letter). How should I go about transferring them to Binance?

[KevinMiller-dg]

Loved this guide! I have a Bitget wallet with just my recovery phrase: (basket ethics arch lend brother credit supply poverty borrow deer treat guitar). How do I move it to Gemini?

[CaryTriana]

With Trump's re-election, both US stocks and Bitcoin are seeing strong gains. I'm eyeing the potential for more market volatility, but Bitcoin's all-time high is interesting. With inflation and interest rates on the rise, I'm wondering if this is a good time to dive deeper into stocks or focus on crypto for diversification. Any thoughts on balancing both?

[GeorgeFitness-yobl]

DRIP 10 shares of ABBV a month. Great company

[alexis_analysis]

Irritating host keep interrupting. This is not wheel of fortune